Several genes (e.g., PRRC2A, PSMB8, BAG6, GPSM3, PBX2, etc.)have been identified with molecular commonalities in MetS and RA, AS, SLE and SS, which may serve as potential targets for shared treatments. Here, PRRC2A is linked to metabolic syndrome.